140 related articles for article (PubMed ID: 2226260)
21. [Cooperation of B- and T-lymphocytes of the human in vitro and in vivo].
Ambrosius H; Schäffner H
Z Gesamte Inn Med; 1980 Jan; 35(2):38-42. PubMed ID: 6447413
[TBL] [Abstract][Full Text] [Related]
22. Host factors important in immune surveillance against tumours.
Ada GL
IARC Sci Publ; 1982; (39):223-39. PubMed ID: 6185418
[TBL] [Abstract][Full Text] [Related]
23. Influence of early life events on immune reactivity in adult mice.
Neveu PJ; Deleplanque B; Puglisi-Allegra S; D'Amato FR; Cabib S
Dev Psychobiol; 1994 May; 27(4):205-13. PubMed ID: 8034114
[TBL] [Abstract][Full Text] [Related]
24. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
[TBL] [Abstract][Full Text] [Related]
25. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
[TBL] [Abstract][Full Text] [Related]
26. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
27. [Immunological profile of patients with neoplastic disease].
Stivala F; Catania G; Basile F; Malaponte G; Bottiglieri C; Giovinetto A
Minerva Chir; 1981 Mar; 36(5):297-302. PubMed ID: 6972495
[No Abstract] [Full Text] [Related]
28. Abnormalities of cellular immunity and natural killer cells in Gaucher's disease.
Burstein Y; Zakuth V; Rechavi G; Spirer Z
J Clin Lab Immunol; 1987 Jul; 23(3):149-51. PubMed ID: 2959782
[TBL] [Abstract][Full Text] [Related]
29. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
[TBL] [Abstract][Full Text] [Related]
30. Cellular mechanisms of antibody production.
Wieczorek Z
Acta Histochem Suppl; 1980; 22():19-26. PubMed ID: 6454903
[No Abstract] [Full Text] [Related]
31. [Activity of non-specific T-suppressors regulating the proliferation of B- and T-lymphocytes in patients with fibroadenomatosis, breast cancer and stomach cancer].
Grinevich IuA; Drannik GN; Nikol'skiĭ IS; Kalinina NA; Litvishchenko EI
Vopr Onkol; 1984; 30(12):23-7. PubMed ID: 6240157
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
33. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
34. [Suppressor T- and B-lymphocytes].
Khaitov RM
Probl Gematol Pereliv Krovi; 1981 Oct; 26(10):48-54. PubMed ID: 6459576
[No Abstract] [Full Text] [Related]
35. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
Cristaldi M; Rovati M; Elli M; Gerlinzani S; Lesma A; Balzarotti L; Taschieri AM
Surg Laparosc Endosc; 1997 Jun; 7(3):255-61. PubMed ID: 9194291
[TBL] [Abstract][Full Text] [Related]
36. [Immunoactive effects of various mistletoe lectin-1 dosages in mammary carcinoma patients].
Beuth J; Stoffel B; Ko HL; Buss G; Tunggal L; Pulverer G
Arzneimittelforschung; 1995 Apr; 45(4):505-7. PubMed ID: 7779151
[TBL] [Abstract][Full Text] [Related]
37. Increase of regulatory T cells in the peripheral blood of cancer patients.
Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B
Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425
[TBL] [Abstract][Full Text] [Related]
38. [Immune tolerance].
Seman M
Rev Prat; 1994 Jan; 44(1):32-5. PubMed ID: 8178055
[TBL] [Abstract][Full Text] [Related]
39. Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer, PIN and BPH.
Kastelan M; Kovacić K; Tarle R; Kraljić I; Tarle M
Anticancer Res; 1997; 17(3B):1671-5. PubMed ID: 9179216
[TBL] [Abstract][Full Text] [Related]
40. Immunological studies on Crohn's disease. II. Lack of evidence for humoral and cellular dysfunctions.
Fujita K; Okabe N; Yao T
J Clin Lab Immunol; 1985 Mar; 16(3):155-61. PubMed ID: 3162025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
